These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 27629416)
21. O-glycosylation in Toxoplasma gondii: identification and analysis of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Stwora-Wojczyk MM; Kissinger JC; Spitalnik SL; Wojczyk BS Int J Parasitol; 2004 Mar; 34(3):309-22. PubMed ID: 15003492 [TBL] [Abstract][Full Text] [Related]
22. Isoform-specific regulation of osteogenic factors by polypeptide N-Acetylgalactosaminyltransferases 1 and 4. Tang J; Zheng H; Chen L; Gao S; Shi X; Liu J; Xu L Biochem Biophys Res Commun; 2017 Jan; 482(4):1449-1454. PubMed ID: 27965094 [TBL] [Abstract][Full Text] [Related]
23. Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats. Gerken TA; Tep C; Rarick J Biochemistry; 2004 Aug; 43(30):9888-900. PubMed ID: 15274643 [TBL] [Abstract][Full Text] [Related]
24. A functional polypeptide N-acetylgalactosaminyltransferase (PGANT) initiates O-glycosylation in cultured silkworm BmN4 cells. Xu J; Morio A; Morokuma D; Nagata Y; Hino M; Masuda A; Li Z; Mon H; Kusakabe T; Lee JM Appl Microbiol Biotechnol; 2018 Oct; 102(20):8783-8797. PubMed ID: 30136207 [TBL] [Abstract][Full Text] [Related]
25. Identification of a novel human UDP-GalNAc transferase with unique catalytic activity and expression profile. Peng C; Togayachi A; Kwon YD; Xie C; Wu G; Zou X; Sato T; Ito H; Tachibana K; Kubota T; Noce T; Narimatsu H; Zhang Y Biochem Biophys Res Commun; 2010 Nov; 402(4):680-6. PubMed ID: 20977886 [TBL] [Abstract][Full Text] [Related]
26. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma. Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292 [TBL] [Abstract][Full Text] [Related]
27. Revisiting the human polypeptide GalNAc-T1 and T13 paralogs. Festari MF; Trajtenberg F; Berois N; Pantano S; Revoredo L; Kong Y; Solari-Saquieres P; Narimatsu Y; Freire T; Bay S; Robello C; Bénard J; Gerken TA; Clausen H; Osinaga E Glycobiology; 2017 Jan; 27(2):140-153. PubMed ID: 27913570 [TBL] [Abstract][Full Text] [Related]
28. Trimeric Tn antigen on syndecan 1 produced by ppGalNAc-T13 enhances cancer metastasis via a complex formation with integrin α5β1 and matrix metalloproteinase 9. Matsumoto Y; Zhang Q; Akita K; Nakada H; Hamamura K; Tsuchida A; Okajima T; Furukawa K; Urano T; Furukawa K J Biol Chem; 2013 Aug; 288(33):24264-76. PubMed ID: 23814067 [TBL] [Abstract][Full Text] [Related]
29. An acetylation site in lectin domain modulates the biological activity of polypeptide GalNAc-transferase-2. Zlocowski N; Lorenz V; Bennett EP; Clausen H; Nores GA; Irazoqui FJ Biol Chem; 2013 Jan; 394(1):69-77. PubMed ID: 23096348 [TBL] [Abstract][Full Text] [Related]
30. regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2. Liu J; Yang L; Jin M; Xu L; Wu S Mol Med Rep; 2011; 4(6):1299-305. PubMed ID: 21874244 [TBL] [Abstract][Full Text] [Related]
31. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat. Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048 [TBL] [Abstract][Full Text] [Related]
32. ppGalNAc T1 as a potential novel marker for human bladder cancer. Ding MX; Wang HF; Wang JS; Zhan H; Zuo YG; Yang DL; Liu JY; Wang W; Ke CX; Yan RP Asian Pac J Cancer Prev; 2012; 13(11):5653-7. PubMed ID: 23317233 [TBL] [Abstract][Full Text] [Related]
34. Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates. Gerken TA; Raman J; Fritz TA; Jamison O J Biol Chem; 2006 Oct; 281(43):32403-16. PubMed ID: 16912039 [TBL] [Abstract][Full Text] [Related]
35. Catalytic and glycan-binding abilities of ppGalNAc-T2 are regulated by acetylation. Zlocowski N; Sendra VG; Lorenz V; Villarreal MA; Jorge A; Núñez Y; Bennett EP; Clausen H; Nores GA; Irazoqui FJ Biochem Biophys Res Commun; 2011 Jun; 410(1):140-5. PubMed ID: 21651894 [TBL] [Abstract][Full Text] [Related]
36. Specificity of O-glycosylation by bovine colostrum UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase using synthetic glycopeptide substrates. Brockhausen I; Toki D; Brockhausen J; Peters S; Bielfeldt T; Kleen A; Paulsen H; Meldal M; Hagen F; Tabak LA Glycoconj J; 1996 Oct; 13(5):849-56. PubMed ID: 8910012 [TBL] [Abstract][Full Text] [Related]
37. Inhibitor of ppGalNAc-T3-mediated O-glycosylation blocks cancer cell invasiveness and lowers FGF23 levels. Song L; Linstedt AD Elife; 2017 Mar; 6():. PubMed ID: 28362263 [TBL] [Abstract][Full Text] [Related]